Show simple item record

Consensus Guidelines for Interventional Cardiology Services Delivery During COVID-19 Pandemic in Australia and New Zealand

Export
FieldValueLanguage
dc.contributor.authorLo, S.T.H.en
dc.contributor.authorYong, A.S.en
dc.contributor.authorSinhal, A.en
dc.contributor.authorShetty, S.en
dc.contributor.authorMcCann, A.en
dc.contributor.authorClark, D.en
dc.contributor.authorGalligan, L.en
dc.contributor.authorEl-Jack, S.en
dc.contributor.authorSader, M.en
dc.contributor.authorTan, R.en
dc.contributor.authorHallani, H.en
dc.contributor.authorBarlis, P.en
dc.contributor.authorSechi, R.en
dc.contributor.authorDictado, E.en
dc.contributor.authorWalton, A.en
dc.contributor.authorStarmer, G.en
dc.contributor.authorBhagwandeen, R.en
dc.contributor.authorLeung, D.Y.en
dc.contributor.authorJuergens, C.P.en
dc.contributor.authorBhindi, R.en
dc.contributor.authorMuller, D.W.M.en
dc.contributor.authorRajaratnum, R.en
dc.contributor.authorFrench, J.K.en
dc.contributor.authorKritharides, L.en
dc.contributor.authorgroup, on behalf of the Interventional council of CSANZ and COVID-19 Interventional cardiology workingen
dc.date.accessioned2020-05-27
dc.date.available2020-05-27
dc.date.issued2020en
dc.identifier.urihttps://hdl.handle.net/2123/22375
dc.description.abstractThe global COVID-19 pandemic poses an unprecedented stress on healthcare systems internationally. These Health system-wide demands call for efficient utilisation of resources at this time in a fair, consistent, ethical and efficient manner would improve our ability to treat patients. Excellent co-operation between hospital units (especially ICU, ED and cardiology) is critical in ensuring optimal patient outcomes. The purpose of this document is to provide practical guide lines for the effective use of interventional cardiology services in Australia and New Zealand. The document will be updated regularly as new evidence and knowledge is gained 55 with time.en
dc.language.isoenen
dc.rightsOther
dc.subjectCOVID-19en
dc.subjectCoronavirusen
dc.titleConsensus Guidelines for Interventional Cardiology Services Delivery During COVID-19 Pandemic in Australia and New Zealanden
dc.typeArticleen
dc.identifier.doi10.1016/j.hlc.2020.04.002
dc.relation.otherAstraZeneca (United Kingdom)en
dc.relation.otherAbbott (United States)en
dc.relation.otherMedtronic (United States)en
dc.relation.otherEdwards Lifesciences (United States)en
dc.relation.otherBoehringer Ingelheim (United States)en
dc.relation.otherBayer (United States)en
dc.relation.otherBoston Scientific (United States)en
dc.relation.otherPfizer (United States)en
usyd.facultyFaculty of Medicine and Health, Sydney Medical Schoolen


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

Version history

There are no previous versions of the item available.